InBody Scholar

InBody continues to work closely with academic researchers on a global scale to develop more in-depth clinical applications of body composition.
With our long history in the industry, we provide more than 6,000 research and publications.
Research title with ★ indicates InBody recommended paper.

Effect of cilostazol on carotid plaque volume measured by 3D ultrasound in patients with type 2 diabetes: FANCY study.

Lee et al.
Used Parameters : BFM, PBF, VFA

Publication Year : 2020

Country : Korea

Journal : Diabetes Obes Metab

AIMS: We conducted a prospective randomized study to evaluate cilostazol, a phosphodiesterase III inhibitor, and compare it with aspirin for the prevention of the progression of atherosclerosis in patients with type 2 diabetes (T2D). MATERIALS AND METHODS: Fifty patients with T2D and carotid atherosclerotic plaques were randomly assigned to either 200 mg/day cilostazol (CTZ) or 100 mg/day aspirin (ASA) groups for 6 months. The primary end point was change in plaque volume measured by carotid 3D …
Full text